These data are consistent with the recent study (27) in suggesting that glutamine consumption may be increased in G6PD mutant melanomas partly to restore the levels of TCA cycle intermediates that are consumed by increased malic enzyme and isocitrate dehydrogenase function. The gene discussed is IDH3A; the disease is melanoma.